By matching clinical information and the MYC target gene expression profile in osteosarcoma patient samples, next, a risk signature incorporating 10 MYC target genes in the TARGET cohort turned out to be an independent prognostic factor in patients suffering from osteosarcoma. Here, MYC is linked to osteosarcoma.